Souhaitez-vous accéder aux communiqués récents ?

CAMBRIDGE, Mass., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...

Top-line Results of Phase 3 STATUS Trial for SAGE-547 in SRSE Expected in 2H 2016 Robust, Wholly-Owned Pipeline Includes 6 Novel Compounds in Evaluation across Multiple CNS Indications 3 Clinical...

DENVER, Jan. 14, 2016 (GLOBE NEWSWIRE) -- Lilis Energy (NASDAQ:LLEX), a domestic oil and gas exploration and production company focused in the Denver-Julesburg (DJ) Basin, has announced the...

BOSTON, MA--(Marketwired - Jan 11, 2016) - Cambridge Associates, the global investment advisor to institutions and private clients, has expanded the leadership of its global pensions practice,...

CAMBRIDGE, Mass., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative...

CAMBRIDGE, Mass., Dec. 4, 2015 (GLOBE NEWSWIRE) -- Dimension Therapeutics, Inc. (NASDAQ:DMTX), a leading gene therapy company advancing novel, liver-directed treatments for diverse rare diseases,...

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Nov. 9, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of...

CAMBRIDGE, MA, MASS., Nov. 5, 2015 (GLOBE NEWSWIRE) -- Cyteir Therapeutics, a Cambridge-based biopharmaceutical company, announced today the close of a Series A financing totaling $5.5 million....

PALO ALTO, CA and CAMBRIDGE, MA--(Marketwired - Nov 2, 2015) - Jennifer Holmstrom, formerly a leader on Facebook's executive search team, has joined Highland Capital Partners as a Talent Partner....

AMSTERDAM, The Netherlands and HOLZGERLINGEN, Germany, Oct. 29, 2015 (GLOBE NEWSWIRE) -- Curetis B.V.1 ("Curetis"), a developer of next-level molecular diagnostic solutions, today announced the...